Human Fibrinogen - search results

ইউরোপীয় ইউনিয়ন - আইসল্যান্ডীয় - EMA (European Medicines Agency)

mixtard

novo nordisk a/s - insulin human - sykursýki - lyf notuð við sykursýki - meðferð sykursýki.

ইউরোপীয় ইউনিয়ন - আইসল্যান্ডীয় - EMA (European Medicines Agency)

protaphane

novo nordisk a/s - insulin human - sykursýki - lyf notuð við sykursýki - meðferð sykursýki.

ইউরোপীয় ইউনিয়ন - আইসল্যান্ডীয় - EMA (European Medicines Agency)

insuman

sanofi-aventis deutschland gmbh - insulin human - sykursýki - lyf notuð við sykursýki - sykursýki þar sem meðferð með insúlíni er þörf. insuman rapid er einnig hentugur til meðhöndlunar á blóðsykurshækkun og ketónblóðsýringu, auk þess að ná fram stöðugleika fyrir og innan og eftir aðgerð hjá sjúklingum með sykursýki.

ইউরোপীয় ইউনিয়ন - আইসল্যান্ডীয় - EMA (European Medicines Agency)

inpremzia

baxter holding b.v. - insulin human (rdna) - sykursýki - lyf notuð við sykursýki - inpremzia is indicated for the treatment of diabetes mellitus.

ইউরোপীয় ইউনিয়ন - আইসল্যান্ডীয় - EMA (European Medicines Agency)

bimervax

hipra human health s.l. - sars-cov-2 virus recombinant spike (s) protein receptor binding domain (rbd) fusion heterodimer – b.1.351-b.1.1.7 strains - covid-19 virus infection - bóluefni - bimervax is indicated as a booster for active immunisation to prevent covid-19 in individuals 16 years of age and older who have previously received a mrna covid-19 vaccine.